123 related articles for article (PubMed ID: 12062503)
1. In vivo evaluation of matrix pellets containing nanocrystalline ketoprofen.
Vergote GJ; Vervaet C; Van Driessche I; Hoste S; De Smedt S; Demeester J; Jain RA; Ruddy S; Remon JP
Int J Pharm; 2002 Jun; 240(1-2):79-84. PubMed ID: 12062503
[TBL] [Abstract][Full Text] [Related]
2. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen.
Vergote GJ; Vervaet C; Van Driessche I; Hoste S; De Smedt S; Demeester J; Jain RA; Ruddy S; Remon JP
Int J Pharm; 2001 May; 219(1-2):81-7. PubMed ID: 11337168
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects.
Lorier M; Magallanes L; Ibarra M; Guevara N; Vázquez M; Fagiolino P
Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):787-793. PubMed ID: 26590950
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of ketoprofen bioavailability by formation of microsponge tablets.
Comoglu T; Savaşer A; Ozkan Y; Gönül N; Baykara T
Pharmazie; 2007 Jan; 62(1):51-4. PubMed ID: 17294814
[TBL] [Abstract][Full Text] [Related]
5. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluations of ketoprofen extended release pellets prepared using powder layering technique in a rotary centrifugal granulator.
Pai R; Kohli K; Jain G; Srivastava B
Arch Pharm Res; 2011 Jul; 34(7):1135-42. PubMed ID: 21811920
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of the individual enantiomer S-(+)-ketoprofen after intravenous and oral administration in dogs at two dose levels.
Serrano-Rodríguez JM; Serrano JM; Rodríguez JM; Machuca MM; Gómez-Villamandos RJ; Navarrete-Calvo R
Res Vet Sci; 2014 Jun; 96(3):523-5. PubMed ID: 24746290
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of a new ketoprofen formulation for once-daily oral administration.
Roda A; Sabatini L; Mirasoli M; Baraldini M; Roda E
Int J Pharm; 2002 Jul; 241(1):165-72. PubMed ID: 12086732
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bioequivalence after oral, intramuscular, and intravenous administration of racemic ketoprofen in pigs.
Raekallio MR; Mustonen KM; Heinonen ML; Peltoniemi OA; Säkkinen MS; Peltoniemi SM; Honkavaara JM; Vainio OM
Am J Vet Res; 2008 Jan; 69(1):108-13. PubMed ID: 18167095
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of ketoprofen in horses after rectal administration.
Corveleyn S; Deprez P; Van der Weken G; Baeyens W; Remon JP
J Vet Pharmacol Ther; 1996 Oct; 19(5):359-63. PubMed ID: 8905569
[TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of ketoprofen in suspension and solution formulations in rats: the influence of poloxamer 188.
Fischer SM; Parmentier J; Buckley ST; Reimold I; Brandl M; Fricker G
J Pharm Pharmacol; 2012 Nov; 64(11):1631-7. PubMed ID: 23058050
[TBL] [Abstract][Full Text] [Related]
12. Compacted Multiparticulate Systems for Colon-Specific Delivery of Ketoprofen.
de Alencar RG; de Oliveira AC; Lima EM; da Cunha-Filho MSS; Taveira SF; Marreto RN
AAPS PharmSciTech; 2017 Aug; 18(6):2260-2268. PubMed ID: 28074422
[TBL] [Abstract][Full Text] [Related]
13. Influence of formulation on the pharmacokinetics and bioavailability of racemic ketoprofen in horses.
Landoni MF; Lees P
J Vet Pharmacol Ther; 1995 Dec; 18(6):446-50. PubMed ID: 8789698
[TBL] [Abstract][Full Text] [Related]
14. Compressed biodegradable matrices of spray-dried PLGA microspheres for the modified release of ketoprofen.
Gavini E; Sanna V; Juliano C; Giunchedi P
J Microencapsul; 2003; 20(2):193-201. PubMed ID: 12554374
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet.
Wei Q; Yang F; Luan L
Drug Dev Ind Pharm; 2013 Jun; 39(6):928-34. PubMed ID: 22401710
[TBL] [Abstract][Full Text] [Related]
16. A new approach for preparing a controlled release ketoprofen tablets by using beeswax.
Uner M; Gönüllü U; Yener G; Altinkurt T
Farmaco; 2005 Jan; 60(1):27-31. PubMed ID: 15652365
[TBL] [Abstract][Full Text] [Related]
17. Pilot study of relative bioavailability of two oral formulations of ketoprofen 25 mg in healthy subjects. A fast-dissolving lyophilized tablet as compared to immediate release tablet.
Ahmed IS; Fatahalla FA
Drug Dev Ind Pharm; 2007 May; 33(5):505-11. PubMed ID: 17520441
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective Conversion of Ketoprofen in Men Versus Women from Two Different Oral Dosage Formulations: Observations and Introspection of the Pharmacokinetic Data.
Dash RP; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):165-166. PubMed ID: 28101840
[No Abstract] [Full Text] [Related]
19. Formulation and in vitro-in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration.
Mathew ST; Devi SG; Prasanth VV; Vinod B
J Microencapsul; 2009 Aug; 26(5):456-69. PubMed ID: 19606940
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective pharmacokinetics of ketoprofen in llamas following intravenous administration.
Navarre CB; Ravis WR; Campbell J; Nagilla R; Duran SH; Pugh DG
J Vet Pharmacol Ther; 2001 Jun; 24(3):223-6. PubMed ID: 11442802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
